Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Torre

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical and Experimental Dermatology|November 8, 2023
Argentine dermatology and ChatGPT: infrequent use and intermediate stanceEry A Ko, Ana C Torre, Barbara Hernandez, et al.
Medicina|October 23, 2023
[Practical update for the diagnosis and treatment of chronic urticaria]Marta P La Forgia, Ana C Torre, Andrea Song, et al.
Medicina|November 30, 2020
[Validation of a Spanish questionnaire on telemedicine usability]Nuria Bibiloni, Ana C Torre, Maria V Angles, et al.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Medicina|August 28, 2021
[Dermatological emergencies. Prospective and multicentric study in Argentina]Patricia A Fernández Pardal, Ana C Torre, Agustina Rodrigo, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical and Experimental Dermatology|November 8, 2023
Argentine dermatology and ChatGPT: infrequent use and intermediate stanceEry A Ko, Ana C Torre, Barbara Hernandez, et al.
Medicina|October 23, 2023
[Practical update for the diagnosis and treatment of chronic urticaria]Marta P La Forgia, Ana C Torre, Andrea Song, et al.
Medicina|November 30, 2020
[Validation of a Spanish questionnaire on telemedicine usability]Nuria Bibiloni, Ana C Torre, Maria V Angles, et al.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Medicina|August 28, 2021
[Dermatological emergencies. Prospective and multicentric study in Argentina]Patricia A Fernández Pardal, Ana C Torre, Agustina Rodrigo, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 2